January 6, 2016
LivaNova: “FDA’s Warning Letter can be resolved without material impact on financial results”
LivaNova said that FDA’s Warning Letter can be resolved without a material impact on financial results.
Pharmaceuticals, Biotechnology and Life Sciences
LivaNova said that FDA’s Warning Letter can be resolved without a material impact on financial results.